1 Nov 2018 - 2 Nov 2018 | Potsdam-Golm, Germany
Hero Image
1 Nov 2018 - 2 Nov 2018
Potsdam-Golm, Germany
10th Potsdam Days on Bioanalysis 2018

Biotechnology and pharma in Berlin-Brandenburg

The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value- added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.

HealthCapital Berlin Brandenburg

With more than 230 biotechnology companies, 30 pharmaceutical companies, 35 major research facilities and institutions of higher education with a life sciences focus and over 130 clinics, Berlin-Brandenburg is already a European hot spot for the life sciences. Growth in expertise, players and investment will reinforce the capital region’s leading position in the international markets.

The companies in the Berlin-Brandenburg region are attracted by the exceptional potential for development and cooperation, characterized in particular by direct access to academic and scientific institutions. The long-standing networks and research groups of the region promote the growth and development processes of individual companies.

For more Information please check here.


Closed since 31 October 2018


IAP Fraunhofer Conference Center

Organised by


Australia 1
Austria 1
Denmark 1
Germany 107
Japan 1
Switzerland 1
United States 1
Total 113


Company 61
University 21
R&D Institution 12
Association/Agency 5
Authority/Government 1
Other 13
Total 113